PROGRAMMA - SIF

THURSDAY, October 15, 2009
THURSDAY, October 15, 2009
Sala Rossa – 8.30-10.30 am
Oral Communications
PHARMACOGENETICS
Chairpersons: Fornasari D. (Milan),
Genazzani A. (Novara)
8.30 am ASSOCIATION BETWEEN GENOTYPES AND RESPONSE TO
IMATINIB MESYLATE TREATMENT IN A SUBSET OF
PREVIOUSLY UNTREATED PATIENTS AFFECTED BY
GASTROINTESTINAL STROMAL TUMOURS
Angelini S., Pantaleo M., Turrini E., Di Battista M., Biasco
G., Cantelli Forti G., Hrelia P. (Bologna)
8.45 am DIFFERENT RESPONSE TO DRUG THERAPY FROM
OSTEOPOROTIC PATIENTS
Conti V., Rinaldi B., Russomanno G., Toro A., Tripodi F.,
Ciaramella N., Ruggiero F., Rossi F. (Naples, Mercato San
Severino)
9.00 am ADVERSE REACTIONS TO COMT INHIBITORS IN
PARKINSON’S DISEASE PATIENTS: POSSIBLE
ASSOCIATION WITH THE UGT1A9 GENE HAPLOTYPE
Ferrari M., Loraschi A., Marino F., Riboldazzi G., Zangaglia
R., Pianezzola C., Bono G., Lecchini S., Nappi G., Martignoli
E., Cosentino M. (Varese, Pavia, Veruno, Rome)
9.15 am EFFECTS OF CELECOXIB ON PROSTANOID BIOSYNTHESIS
AND INFLAMMATORY AND ANGIOGENIC BIOMARKERS IN
PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS
Tacconelli S., Capone M., Dovizio M., Bruno A., Sciulli M.,
Sala P., Signorini S., Bertario L., Dixon D., Lawson J.,
FitzGerald G., Patrignani P. (Chieti, Milan, Columbia,
Philadelphia)
9.30 am IMPACT OF CYP2C9 AND VKORC1 POLYMORPHISMS ON
PHARMACOKINETICS AND PHARMACODYNAMICS OF
WARFARIN IN PATIENTS ON ANTICOAGULANT THERAPY
Nisi A., Schiavon S., Zambon C., De Rosa G., Basso D.,
Pengo V., Gusella M., Plebani M., Padrini R. (Padua,
Rovigo)
9.45 am EVALUATION OF DRUG RESPONSES IN NON-
TRANSFORMED CELLS CARRYING CANCER ALLELES
Gallicchio M., Di Nicolantonio F., Arena S., Zecchin D.,
Martini M., Flonta S., Stella G., Lamba S., Cancelliere C.,
14
Russo M., Geuna M., Appendino G., Fantozzi R., Medico E.,
Bardelli A. (Turin, Candiolo, Pavia, Novara, Milan)
10.00 am ANALYSIS OF SEROTONIN TRANSPORTER 5HTTLPR AND
CHOLECYSTOKININ TYPE 1 RECEPTOR GENE
POLYMORPHISMS, CLINICAL VARIANTS AND SYMPTOM
SEVERITY IN PATIENTS WITH IRRITABLE BOWEL
SYNDROME
Ghisu N., Colucci R., Bellini M., Rossi G., Gambaccini D.,
Blandizzi C., Costa F., Marchi S., Del Tacca M. (Pisa)
10.15 am GENETIC FACTORS INCREASE SUSCEPTIBILITY TO TAU
PROTEIN HYPERPHOSPHORYLATION IN THE BRAIN OF
MICE TREATED WITH 3,4-
METHYLENDIOXYMETHAMPHETAMINE (“ECSTASY”)
Biagioni F., Busceti C., Bucci D., Mastroiacovo F., Riozzi
B., Battaglia G., Bruno V., Cassano T., Cuomo V., Fornai
F., Nicoletti F. (Pozzilli, Rome, Foggia, Pisa)
15
THURSDAY, October 15, 2009